obagi-c c-rx system normal-dry skin intervention

Generic: hydroquinone, titanium dioxide, zinc oxide

Labeler: obagi cosmeceuticals llc
NDC Directory HUMAN OTC DRUG UNAPPROVED DRUG OTHER Inactive Finished

Drug Facts

Product Profile

Brand Name obagi-c c-rx system normal-dry skin intervention
Generic Name hydroquinone, titanium dioxide, zinc oxide
Labeler obagi cosmeceuticals llc
Dosage Form KIT
Manufacturer
Obagi Cosmeceuticals LLC

Identifiers & Regulatory

Product NDC 62032-922
Product ID 62032-922_379fa44a-bdd2-4048-8b45-1fec370a3788
Product Type HUMAN OTC DRUG
Marketing Category UNAPPROVED DRUG OTHER
Listing Expiration 2026-12-31
Marketing Start 2019-12-02

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62032922
Hyphenated Format 62032-922

Supplemental Identifiers

RxCUI
197795

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name obagi-c c-rx system normal-dry skin intervention (source: ndc)
Generic Name hydroquinone, titanium dioxide, zinc oxide (source: ndc)

Resolved Composition

Strengths
  • 6.2 %
  • 15.6 %
source: label
Packaging
  • 1 KIT in 1 BAG (62032-922-01) * 1 TUBE in 1 CARTON (62032-811-09) / 85 g in 1 TUBE * 177 mL in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC (62032-105-36) * 1 BOTTLE, GLASS in 1 CARTON (62032-106-10) / 30 mL in 1 BOTTLE, GLASS
source: ndc

Packages (1)

62032-922-01 1 KIT in 1 BAG (62032-922-01) * 1 TUBE in 1 CARTON (62032-811-09) / 85 g in 1 TUBE * 177 mL in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC (62032-105-36) * 1 BOTTLE, GLASS in 1 CARTON (62032-106-10) / 30 mL in 1 BOTTLE, GLASS

Ingredients (0)

No ingredient records.

Linked Drug Pages (1)

Obagi-C C-Rx System Normal-Dry Skin Intervention ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "379fa44a-bdd2-4048-8b45-1fec370a3788", "openfda": {"rxcui": ["197795"], "spl_set_id": ["e9d8488f-b902-45f4-a6d6-c6eb393c8f08"], "manufacturer_name": ["Obagi Cosmeceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 BAG (62032-922-01)  *  1 TUBE in 1 CARTON (62032-811-09)  / 85 g in 1 TUBE *  177 mL in 1 BOTTLE, PLASTIC *  57 g in 1 BOTTLE, PLASTIC *  57 g in 1 BOTTLE, PLASTIC (62032-105-36)  *  1 BOTTLE, GLASS in 1 CARTON (62032-106-10)  / 30 mL in 1 BOTTLE, GLASS", "package_ndc": "62032-922-01", "marketing_start_date": "20250625"}], "brand_name": "Obagi-C C-Rx System Normal-Dry Skin Intervention", "product_id": "62032-922_379fa44a-bdd2-4048-8b45-1fec370a3788", "dosage_form": "KIT", "product_ndc": "62032-922", "generic_name": "HYDROQUINONE, TITANIUM DIOXIDE, ZINC OXIDE", "labeler_name": "Obagi Cosmeceuticals LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Obagi-C C-Rx System Normal-Dry Skin Intervention", "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20191202", "listing_expiration_date": "20261231"}